ClinicalTrials.govpublic full text
Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma
relapsed follicular lymphoma, refractory follicular lymphoma, loncastuximab tesirine, follicular lymphoma, lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 872824
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.